D. Mark McClung
2020
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $136,245 |
| Option Awards | $1,187,220 |
| Salary | $276,667 |
| Stock Awards | $916,000 |
| Other | $5,093 |
| Total | $2,671,225 |
McClung received $1.2M in option awards, accounting for 44% of the total pay in 2020.
McClung also received $150K in bonus, $136.2K in non-equity incentive plan, $276.7K in salary, $916K in stock awards and $5.1K in other compensation.
Rankings
In 2020, D. Mark McClung's compensation ranked 4,297th out of 13,090 executives tracked by ExecPay. In other words, McClung earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,297 out of 13,090 | 67th |
Division Manufacturing | 1,737 out of 5,620 | 69th |
Major group Chemicals And Allied Products | 677 out of 2,253 | 70th |
Industry group Drugs | 578 out of 1,953 | 70th |
Industry Biological Products, Except Diagnostic Substances | 134 out of 411 | 67th |
Pay ratio
| D. Mark McClung's Pay | $2,671,225 |
|---|---|
| Median Employee's Pay | $174,051 |
| Pay Ratio | 15to 1 |
In 2020, the annual total compensation of D. Mark McClung was $2,671,225.
The annual total compensation of the median employee at Sangamo Biosciences was $174,051.
The ratio of D. Mark McClung's pay to the pay of median employee was therefore 15 to one.
McClung's colleagues
We found five more compensation records of executives who worked with D. Mark McClung at Sangamo Biosciences in 2020.
2020
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2020
R Ramelmeier
Sangamo Biosciences
Executive Vice President, Technical Operations
2020
Sung Lee
Sangamo Biosciences
Chief Financial Officer
2020
Stéphane Boissel
Sangamo Biosciences
Former Executive Vice President, Corporate Strategy
2020
Gary Loeb
Sangamo Biosciences